NIH is reinforcing reproducibility expectations, shifting how reviewers assess credibility and forcing applicants to rethink how rigor is built into study design.
Archives
What “Competitive But Not Discussed” Really Signals in NIH Review, and What to Do With It
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.
NIH Draws the Line: New Limits on AI Use and Application Volume
NIH sets new rules: six proposals per year per PI, with strict limits on AI-developed content to protect originality.